You are here

In April 2022, our team was present with a booth at Eurogin in Düsseldorf , a leading conference focusing on Human Papillomavirus (HPV) . It was a great place to share our latest work and stay up to date in the field of cervical cancer and other HPV-related diseases . We have three main takeaways...
Urine sampling: A non-invasive way to improve diagnostic efficiency for ovarian cancer
Ovarian cancer (OC) is the seventh most common malignancy among women worldwide. More than 70% of women present the disease at an advanced stage, making the cancer type the most lethal of all gynecological malignancies.
Think outside (the blood collection tube) box: non-invasive sample types for cancer and infectious disease testing
Due to the recent surge in COVID-19 cases, including variants such as Omicron and its associated supply chain issues, the FDA announced an update to their device shortage list to include all blood specimen collection tubes . Their recommendations are to employ conservation strategies, including...
Urine: a preferred sample type for HPV detection
Urine as a sample type is well-accepted, and often preferred by women. As urine can detect HPV, the most common cause of cervical cancer, the sample type has potential to reach a wider population for cervical cancer screening.
At-home urine sampling: A way to continue healthcare practices to prevent the next global health crisis COVID-19 disrupted important cancer screening The COVID-19 pandemic has brought several challenges to healthcare . Lockdowns and fear of getting the infection caused many patients to cancel or...
Celebrating Women and Girls in Science
Celebrating Women and Girls in Science On International Day of Women and Girls in Science , Novosanis celebrates all women that have contributed to scientific advancements and research . This year, we want to recognize four key women who have made significant contributions and advances in the...
Given the challenges with some traditional screening and detection methods, researchers are continuously exploring alternative methods to detect cancer types.
The number of scientific and peer-reviewed publications highlighting the role of first-void urine in the detection, screening, and research of HPV has increased with time. In this blog post, we recap and summarize the 2021 peer-reviewed publications that used Novosanis’ Colli-Pee® for HPV-related research.
Urine as a sample type to understand Chlamydia prevalence in the Belgian population
Chlamydia trachomatis (C. Trachomatis) is a common sexually transmitted infection (STI). In Europe the distribution and prevalence of chlamydia infections is expected to be higher than reported as many asymptomatic infections are not detected. Sciensano set-up two studies using urine samples to analyze for presence of Chlamydia DNA.
Urine the golden sample for HPV-related research? Highlights from the virtual IPVC conference 2021
Novosanis participated in the virtual IPVC conference (from November 15 to 19, 2021), which focused on Human Papilloma Virus (HPV)-related topics, particularly Human Papillomavirus (HPV) elimination. The event and the sessions were a great way to stay up to date with the latest scientific developments in the field. The conference had several sessions focused on urine as a sample type for HPV-related research.
Urine: a promising sample type to detect and monitor prostate cancer
Finding new and specific biomarkers for prostate cancer can improve cancer detection and overall patient outcomes. The increasing knowledge of multi-omics has great potential for prostate cancer research. Several biomarker candidates have been identified in urine
Endometrial cancer biomarker detection
Endometrial cancer is the most frequently diagnosed malignancy of the female genital tract and the sixth most common cancer in women globally. Finding a simple, non-invasive test that identifies endometrial cancer effectively could transform the way the disease is detected and improve patient care.